Overview

Use of N-Acetylcysteine (NAC) in Fingernail Biting

Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
To conduct a pilot randomized placebo-controlled feasibility trial of N-acetylcysteine (NAC) in onychophagia, preliminarily assessing the tolerability and effects of this pharmacotherapy on young adults who bite their fingernails. It is proposed that NAC will help decrease fingernail biting.
Phase:
Phase 3
Details
Lead Sponsor:
Kevin Gray
Kevin Gray, MD
Treatments:
Acetylcysteine
N-monoacetylcystine